Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26184725)

  • 1. Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma.
    Karabulut M; Gunaldi M; Alis H; Afsar CU; Karabulut S; Serilmez M; Akarsu C; Seyit H; Aykan NF
    Clin Transl Oncol; 2016 Feb; 18(2):160-71. PubMed ID: 26184725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of serum interleukin-17 levels in colorectal cancer patients.
    Karabulut S; Usul Afsar C; Karabulut M; Kilic L; Alis H; Kones O; Bilgin E; Faruk Aykan N
    J BUON; 2016; 21(5):1137-1145. PubMed ID: 27837615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating mitochondrial stress 70 protein/mortalin and cytosolic Hsp70 in blood: Risk indicators in colorectal cancer.
    Jubran R; Kocsis J; Garam N; Maláti É; Gombos T; Barabás L; Gráf L; Prohászka Z; Fishelson Z
    Int J Cancer; 2017 Dec; 141(11):2329-2335. PubMed ID: 28791678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer.
    Karabulut M; Alis H; Afsar CU; Karabulut S; Kocatas A; Oguz H; Aykan NF
    Biomed Pharmacother; 2015 Jul; 73():140-6. PubMed ID: 26211595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage inflammatory protein-3 alpha (MIP-3a) is a novel serum prognostic marker in patients with colorectal cancer.
    Iwata T; Tanaka K; Inoue Y; Toiyama Y; Hiro J; Fujikawa H; Okugawa Y; Uchida K; Mohri Y; Kusunoki M
    J Surg Oncol; 2013 Feb; 107(2):160-6. PubMed ID: 22926691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum nectin-2 and nectin-4 are diagnostic in lung cancer: which is superior?
    Erturk K; Karaman S; Dagoglu N; Serilmez M; Duranyildiz D; Tas F
    Wien Klin Wochenschr; 2019 Sep; 131(17-18):419-426. PubMed ID: 31440821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating levels of periostin may help identify patients with more aggressive colorectal cancer.
    Ben QW; Zhao Z; Ge SF; Zhou J; Yuan F; Yuan YZ
    Int J Oncol; 2009 Mar; 34(3):821-8. PubMed ID: 19212687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Potential of Nectin Expressions in Colorectal Cancer: An Exploratory Study.
    Kobecki J; Gajdzis P; Mazur G; Chabowski M
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma.
    Karabulut S; Afsar ÇU; Karabulut M; Alış H; Kılıc L; Çikot M; Yasasever CT; Aykan NF
    J Gastrointest Cancer; 2016 Mar; 47(1):47-54. PubMed ID: 26637231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
    Kawamura M; Toiyama Y; Tanaka K; Saigusa S; Okugawa Y; Hiro J; Uchida K; Mohri Y; Inoue Y; Kusunoki M
    Eur J Cancer; 2012 Sep; 48(14):2244-51. PubMed ID: 22197219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients.
    Toiyama Y; Miki C; Inoue Y; Okugawa Y; Tanaka K; Kusunoki M
    Int J Cancer; 2009 Oct; 125(7):1657-62. PubMed ID: 19569242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is serum placental growth factor a prognostic marker for stage III colorectal cancer patients?
    Gomceli I; Tez M; Bostanci EB; Ulas M; Turhan N; Kemik AS; Akoglu M
    Hepatogastroenterology; 2012; 59(117):1437-40. PubMed ID: 22155858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic value of serum periostin in patients with non-small cell lung cancer.
    Xu CH; Wang W; Lin Y; Qian LH; Zhang XW; Wang QB; Yu LK
    Oncotarget; 2017 Mar; 8(12):18746-18753. PubMed ID: 27816968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic, predictive, and prognostic role of serum epithelial cell adhesion molecule (EpCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in breast cancer.
    Karabulut S; Tas F; Tastekin D; Karabulut M; Yasasever CT; Ciftci R; Güveli M; Fayda M; Vatansever S; Serilmez M; Disci R; Aydıner A
    Tumour Biol; 2014 Sep; 35(9):8849-60. PubMed ID: 24891186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum level of endothelial cell-specific molecule-1 and prognosis of colorectal cancer.
    Jiang H; Fu XG; Chen YT
    Genet Mol Res; 2015 May; 14(2):5519-26. PubMed ID: 26125749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.
    Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Kubota K
    Ann Surg Oncol; 2012 Oct; 19(11):3422-31. PubMed ID: 22576063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nectin-4 is a new histological and serological tumor associated marker for breast cancer.
    Fabre-Lafay S; Monville F; Garrido-Urbani S; Berruyer-Pouyet C; Ginestier C; Reymond N; Finetti P; Sauvan R; Adélaïde J; Geneix J; Lecocq E; Popovici C; Dubreuil P; Viens P; Gonçalves A; Charafe-Jauffret E; Jacquemier J; Birnbaum D; Lopez M
    BMC Cancer; 2007 May; 7():73. PubMed ID: 17474988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Colorectal Cancer.
    Kunizaki M; Sawai T; Takeshita H; Tominaga T; Hidaka S; To K; Miyazaki T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2016 Aug; 36(8):4171-5. PubMed ID: 27466527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implications of serum microRNA-21 in colorectal cancer.
    Menéndez P; Padilla D; Villarejo P; Palomino T; Nieto P; Menéndez JM; Rodríguez-Montes JA
    J Surg Oncol; 2013 Nov; 108(6):369-73. PubMed ID: 23970420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nectin-1 Expression in Colorectal Cancer: Is There a Group of Patients with High Risk for Early Disease Recurrence?
    Tampakis A; Tampaki EC; Nonni A; Droeser R; Posabella A; Tsourouflis G; Kontzoglou K; Patsouris E; von Flüe M; Kouraklis G
    Oncology; 2019; 96(6):318-325. PubMed ID: 30917374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.